CHAMPIONS ONCOLOGY, INC. (CSBR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-30. Amounts in USD.

Revenue TTM

0 3.5M 7M 10.5M Q1 '25: 7M Q2 '25: 7M Q3 '25: 7M Q4 '25: 7.5M Q1 '26: 7.7M Q2 '26: 8M Q3 '26: 8.8M Q4 '26: 9.3M Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26

Gross Profit TTM

-24M -16M -8M 0 8M 16M 24M Q1 '25: -21.7M Q2 '25: -22.6M Q3 '25: -21.4M Q4 '25: -20.8M Q1 '26: -21.6M Q2 '26: -21.2M Q3 '26: -22.5M Q4 '26: -21.6M Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q1 '24: -7.5M Q2 '24: -9.5M Q3 '24: -9.6M Q4 '24: -7.4M Q1 '25: -3.5M Q2 '25: -787K Q3 '25: 6.3M Q4 '26: -1.1M Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '26

Net Income TTM

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q1 '24: -7.6M Q2 '24: -9.6M Q3 '24: -9.7M Q4 '24: -7.3M Q1 '25: -3.4M Q2 '25: -598K Q3 '25: 6.4M Q4 '26: -1.1M Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '26

Cost of Revenue TTM

0 15M 30M 45M Q1 '25: 28.8M Q2 '25: 29.6M Q3 '25: 28.4M Q4 '25: 28.4M Q1 '26: 29.3M Q2 '26: 29.1M Q3 '26: 31.4M Q4 '26: 30.9M Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26

Operating Cash Flow TTM

-6M -3M 0 3M 6M 9M Q1 '25: -1.8M Q2 '25: -2.7M Q3 '25: -1.3M Q4 '25: 7.4M Q1 '26: 7.7M Q2 '26: 6.2M Q3 '26: 4.4M Q4 '26: -4.5M Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26

Free Cash Flow TTM

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q1 '25: -2M Q2 '25: -2.9M Q3 '25: -1.4M Q4 '25: 7M Q1 '26: 7.2M Q2 '26: 5.6M Q3 '26: 3.8M Q4 '26: -5M Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 5M 10M 15M Q2 '24: 13.5M Q3 '24: 13.6M Q1 '25: 14M Q2 '25: 14M Q3 '25: 14.4M Q1 '26: 13.8M Q2 '26: 14.5M Q3 '26: 13.9M Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.75 -0.50 -0.25 0.00 0.25 0.50 0.75 Q1 '24: -0.56 Q2 '24: -0.71 Q3 '24: -0.72 Q4 '24: -0.54 Q1 '25: -0.26 Q2 '25: -0.06 Q3 '25: 0.44 Q4 '26: -0.07 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.